Optas LLC’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Buy
1,402
+404
+40% +$112K 0.04% 307
2026
Q1
$295K Sell
998
-764
-43% -$227K 0.04% 317
2025
Q4
$481K Buy
+1,762
New +$479K 0.08% 178
2025
Q3
Sell
-816
Closed -$225K 401
2025
Q2
$225K Hold
816
0.04% 299
2025
Q1
$216K Buy
+816
New +$201K 0.04% 265

Other funds holding CME

Optas LLC's CME Position: Q2 2026 in Review

Optas LLC increased its CME Group (CME) stake by 40% in Q2 2026, buying an estimated $112K and bringing the position to 1,402 shares worth $310K. The position accounts for 0.04% of the portfolio, ranked #307.

Optas LLC first reported a position in CME in Q1 2025 and has held it in 5 quarters since. The position peaked at $481K in Q4 2025. 400 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Optas LLC held 1,402 shares of CME Group worth $310K as of Q2 2026.
  • Optas LLC bought 404 CME Group shares in Q2 2026, an estimated $112K.
  • CME Group made up 0.04% of Optas LLC's portfolio in Q2 2026, its #307 holding.
  • Optas LLC first reported a position in CME Group in Q1 2025 and has held it in 5 quarters since.
  • Optas LLC's CME Group position peaked at $481K in Q4 2025.
  • 400 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.